- Corporate Officers - F
- Formela Jean Francois
Insider Trading History of Formela Jean Francois
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Formela Jean Francois since 2005.
This trader's CIK number is 1030575.
At the time of last reporting, Formela Jean Francois was the Director of Ikena Oncology, Inc.. (stock ticker symbol IKNA).
Also see all insider trading activities at Ikena Oncology, Inc..
Note that in the past
FORMELA JEAN FRANCOIS also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Exelixis, Inc. (EXEL) by Formela Jean Francois
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2005 | EXEL | 0 | $0 | 275,000 | $2,145,275 | 0 | $0 |
Yearly summary of insider trading at Ikena Oncology, Inc. (IKNA) by Formela Jean Francois
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | IKNA | 125,000 | $2,000,000 | 26,278 | $385,571 | 0 | $0 |
Yearly summary of insider trading at Arca Biopharma, Inc. (ABIO) by Formela Jean Francois
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | ABIO | 0 | $0 | 140,000 | $1,058,400 | 0 | $0 |
Yearly summary of insider trading at Horizon Therapeutics Public Ltd Co (HZNP) by Formela Jean Francois
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | HZNP | 828,443 | $2,999,792 | 0 | $0 | 0 | $0 |
| 2011 | HZNP | 369,814 | $3,328,326 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Zyla Life Sciences (EGLT) by Formela Jean Francois
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | EGLT | 41,667 | $500,004 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Intellia Therapeutics, Inc. (NTLA) by Formela Jean Francois
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | NTLA | 0 | $0 | 1,605,321 | $152,741,275 | 0 | $0 |
| 2018 | NTLA | 0 | $0 | 59,303 | $1,524,068 | 0 | $0 |
| 2017 | NTLA | 0 | $0 | 171,132 | $2,729,299 | 0 | $0 |
Yearly summary of insider trading at Nxstage Medical, Inc. (NXTM) by Formela Jean Francois
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2005 | NXTM | 99,923 | $999,230 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Spero Therapeutics, Inc. (SPRO) by Formela Jean Francois
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | SPRO | 428,571 | $5,999,994 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Translate Bio, Inc. (TBIO) by Formela Jean Francois
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | TBIO | 0 | $0 | 2,055,063 | $78,092,394 | 0 | $0 |
| 2020 | TBIO | 0 | $0 | 227,989 | $4,862,335 | 0 | $0 |
Insider trading activities at 9 companies by Formela Jean Francois:
1. Exelixis, Inc. (EXEL)
2. Ikena Oncology, Inc. (IKNA)
3. Arca Biopharma, Inc. (ABIO)
4. Horizon Therapeutics Public Ltd Co (HZNP)
5. Zyla Life Sciences (EGLT)
6. Intellia Therapeutics, Inc. (NTLA)
7. Nxstage Medical, Inc. (NXTM)
8. Spero Therapeutics, Inc. (SPRO)
9. Translate Bio, Inc. (TBIO)
Table 1. Insider trading of Exelixis, Inc. (EXEL) by Formela Jean Francois
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2005-09-07 | EXEL | Sale | 275,000 | 7.80 | 2,145,275 |
Table 2. Insider trading of Ikena Oncology, Inc. (IKNA) by Formela Jean Francois
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-03-30 | IKNA | Buy | 125,000 | 16.00 | 2,000,000 |
| 2021-12-10 | IKNA | Sale | 11,989 | 15.03 | 180,194 |
| 2021-12-13 | IKNA | Sale | 8,330 | 14.64 | 121,951 |
| 2021-12-14 | IKNA | Sale | 5,959 | 14.00 | 83,426 |
Table 3. Insider trading of Arca Biopharma, Inc. (ABIO) by Formela Jean Francois
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-03-29 | ABIO | Sale | 140,000 | 7.56 | 1,058,400 |
Table 4. Insider trading of Horizon Therapeutics Public Ltd Co (HZNP) by Formela Jean Francois
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-03-02 | HZNP | Buy | 828,443 | 3.62 | 2,999,792 |
| 2011-08-02 | HZNP | Buy | 369,814 | 9.00 | 3,328,326 |
Table 5. Insider trading of Zyla Life Sciences (EGLT) by Formela Jean Francois
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-02-11 | EGLT | Buy | 41,667 | 12.00 | 500,004 |
Table 6. Insider trading of Intellia Therapeutics, Inc. (NTLA) by Formela Jean Francois
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-06-28 | NTLA | Sale | 553,376 | 135.32 | 74,880,626 |
| 2021-06-14 | NTLA | Sale | 170,779 | 87.67 | 14,972,194 |
| 2021-06-11 | NTLA | Sale | 30,946 | 85.58 | 2,648,358 |
| 2021-04-29 | NTLA | Sale | 4,513 | 85.43 | 385,545 |
| 2021-04-26 | NTLA | Sale | 806 | 84.93 | 68,453 |
| 2021-04-27 | NTLA | Sale | 210,230 | 86.29 | 18,141,377 |
| 2021-04-28 | NTLA | Sale | 131,926 | 85.76 | 11,313,973 |
| 2021-04-05 | NTLA | Sale | 800 | 84.98 | 67,984 |
| 2021-02-26 | NTLA | Sale | 501,945 | 60.29 | 30,262,765 |
| 2018-07-16 | NTLA | Sale | 6,686 | 31.45 | 210,261 |
| 2018-06-19 | NTLA | Sale | 6,686 | 28.11 | 187,976 |
| 2018-05-16 | NTLA | Sale | 6,686 | 25.04 | 167,390 |
| 2018-03-20 | NTLA | Sale | 39,245 | 24.42 | 958,441 |
| 2017-07-11 | NTLA | Sale | 80,000 | 16.07 | 1,285,600 |
| 2017-07-10 | NTLA | Sale | 40,000 | 16.17 | 646,880 |
| 2017-07-07 | NTLA | Sale | 30,000 | 16.77 | 502,979 |
| 2017-03-09 | NTLA | Sale | 15,628 | 13.85 | 216,432 |
| 2017-03-10 | NTLA | Sale | 5,504 | 14.06 | 77,408 |
Table 7. Insider trading of Nxstage Medical, Inc. (NXTM) by Formela Jean Francois
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2005-10-27 | NXTM | Buy | 99,923 | 10.00 | 999,230 |
Table 8. Insider trading of Spero Therapeutics, Inc. (SPRO) by Formela Jean Francois
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-11-06 | SPRO | Buy | 428,571 | 14.00 | 5,999,994 |
Table 9. Insider trading of Translate Bio, Inc. (TBIO) by Formela Jean Francois
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-09-14 | TBIO | Sale | 2,055,063 | 38.00 | 78,092,394 |
| 2020-12-21 | TBIO | Sale | 56,536 | 25.50 | 1,441,950 |
| 2020-12-22 | TBIO | Sale | 82,565 | 25.46 | 2,102,270 |
| 2020-08-27 | TBIO | Sale | 10,097 | 14.38 | 145,215 |
| 2020-08-25 | TBIO | Sale | 34,410 | 15.00 | 516,150 |
| 2020-08-26 | TBIO | Sale | 44,381 | 14.80 | 656,750 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Formela Jean Francois
(Director of Ikena Oncology, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.